Limitless Allzyme

Limitless Allzyme is an oral proteolytic enzyme combination product containing trypsin, chymotrypsin, and bromelain. Developed by Eva Pharma, it is formulated to exert anti-inflammatory, anti-edematous, and fibrinolytic effects. The mechanism of action involves the proteolytic degradation of fibrin and other proteinaceous inflammatory mediators that accumulate at the site of injury or infection, thereby facilitating the resorption of edema, improving local circulation, and reducing pain. It is frequently utilized in dental and surgical settings to manage conditions such as mandibular abscesses and irreversible pulpitis, often compared to other enzymatic products like Alphintern.

Brand names

Limitless AllzymeLimitless Allzyme Max

Other names

trypsin + chymotrypsin + bromelain